首页> 外文期刊>European journal of pharmaceutical sciences >Dual-mechanism gastroretentive drug delivery system loaded with an amorphous solid dispersion prepared by hot-melt extrusion
【24h】

Dual-mechanism gastroretentive drug delivery system loaded with an amorphous solid dispersion prepared by hot-melt extrusion

机译:用热熔挤出制备的双机械胃内引入药物递送系统,加载无定形固体分散体

获取原文
获取原文并翻译 | 示例

摘要

In the present study, we aimed to prepare a gastroretentive drug delivery system that would be both highly resistant to gastric emptying via multiple mechanisms and would also potentially induce in situ supersaturation. The bioadhesive floating pellets, loaded with an amorphous solid dispersion, were prepared in a single step of hot-melt extrusion technology. Hydroxypropyl cellulose (Klucel (TM) MF) and hypromellose (Benecel (TM) K1 5M) were used as matrix-forming polymers, and felodipine was used as the model drug. The foam pellets were fabricated based on the expansion of CO2, which was generated from sodium bicarbonate during the melt-extrusion process. A 2(n) full factorial experimental design was utilized to investigate the effects of formulation compositions to the pellet properties. The melt-extrusion process transformed the crystalline felodipine into an amorphous state that was dispersed and "frozen" in the polymer matrix. All formulations showed high porosity and were able to float immediately, without lag time, on top of gastric fluid, and maintained their buoyancy over 12 h. The pellet-specific floating force, which could be as high as 4800 mu N/g, increased significantly during the first hour, and was relatively stable until 9 h. The sodium bicarbonate percentage was found to be most significantly effect to the floating force. The ex vivo bioadhesion force of the pellets to porcine stomach mucosa was approximately 5 mN/pellet, which was more than five times higher than the gravitation force of the pellet saturated with water. Drug release was well controlled up to 12 h in the sink condition of 0.5% sodium lauryl sulphate in 0.1 N HCl. The dissolution at 1, 3, 5, and 8 h were 5-12%, 25-45%, 55-80%, and >= 75% respectively for all 11 formulations. In biorelevant dissolution medium, a supersaturated solution was formed, and the concentration was maintained at around 2 mu g/mL, approximately 10-folds higher than that of the pure felodipine. All input factors significantly affected dissolution in the first 3 h, but afterwards, only drug load and hypromellose (HPMC) content had significant effects. The prepared drug delivery system has great potential in overcoming low and fluctuating bioavailability of poorly soluble drugs.
机译:在本研究中,我们的目标是制备胃肠过度药物递送系统,这两者都可以通过多种机制耐胃排空,并且还可能诱导原位过饱和。用无定形固体分散体加载的生物粘附颗粒,在一步的热熔挤出技术中制备。使用羟丙基纤维素(Klucel(TM)MF)和杂烯(Benecel(TM)K1 5M)作为形成基质聚合物,并使用Felodipine作为模型药物。基于CO 2的膨胀制造泡沫粒料,其在熔融挤出过程中由碳酸氢钠产生。利用2(n)完整的阶乘实验设计来研究配制组合物对颗粒性质的影响。将熔融挤出工艺转化为分散的无定形状态并在聚合物基质中“冷冻”的非晶态。所有制剂都显示出高孔隙率,并且能够立即漂浮,没有滞后时间,在胃液顶部,并将其浮力保持在12小时内。颗粒特异性浮动力,其可以高达4800 mu n / g,在第一小时内显着增加,并且在9小时之前相对稳定。发现碳酸氢钠百分比对浮动力最显着影响。颗粒的离体生物粘附力为猪胃粘膜约为5mN /颗粒,比饱和水饱和的颗粒的重力力高出五倍以上。在0.1N HCl中,在0.1N HCl中的0.5%十二酸钠硫酸钠的沉淀条件下,药物释放良好。对于所有11种制剂,1,3,5和8小时的溶解分别为5-12%,25-45%,55-80%,> = 75%。在Biorelevant溶解培养基中,形成过饱和溶液,并将浓度保持在约2μg/ mL,高于纯Felodipine的10倍。所有输入因素在前3小时内显着影响溶解,但之后只有药物载荷和杂乳(HPMC)含量有显着效果。制备的药物递送系统具有巨大的潜力克服差异和波动的生物利用度差异不良药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号